A BREAKTHROUGH TREATMENT IS HELPING RESTORE SIGHT FOR PATIENTS. IT USES A SIMPLE GEL DOCTORS ALREADY USE, BUT IN AN ENTIRELY ...

A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...

Allergies and asthma affect an increasing number of children worldwide, but now an international research group led by DTU ...

Baby KJ was the first to receive a bespoke gene-editing treatment. Personalized drugs for others could be approved within the ...

Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production ...

Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to ...

Scientists may have just made a breakthrough in the field of in vitro fertilization (IVF)—one that could sidestep a ...

FDA accepted NDA for zidesamtinib for the treatment of TKI pre-treated patients with advanced ROS1-positive NSCLC; PDUFA target action date of September ...

India’s health care system is undergoing a major shift as genomics and artificial intelligence enable predictive, preventive, ...

Vivasure Medical Limited ('Vivasure”) has been a strategic holding of Orchestra BioMed since the Company’s formation NEW HOPE, Pa., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc.

The CGuard® Prime Carotid Stent System demonstrated the lowest 30-day and 1-year primary endpoint major adverse event rates of any pivotal study of carotid stenting (CAS) ...

Researchers from SAHMRI, SA Pathology and the University of Adelaide have developed a new, highly targeted therapeutic ...